Literature DB >> 2816861

Relative carnitine insufficiency in children with type I diabetes mellitus.

S C Winter1, M Simon, E M Zorn, S Szabo-Aczel, W H Vance, T O'Hara, L Higashi.   

Abstract

Recognizing the similarity of type I diabetes mellitus to inborn errors of metabolism that have responded to carnitine therapy, we initiated a study of 54 children with type I diabetes mellitus. Examining a fasting blood sample for levels of carnitine, glucose, and glycosylated hemoglobin A1c, and a urine sample for levels of ketones and glucose, we found 13 children were deficient of free carnitine (less than 20 mumol/L) and 30 had elevated acyl carnitine levels (greater than 11 mumol/L). Statistical tests confirmed a significant difference between the diabetic population and normal population for reduced free carnitine, elevated acyl carnitine, and an elevated ratio of acyl carnitine to free carnitine. Also, a significant correlation was found between the levels of urine glucose and ketones and the level of acyl carnitine. Our data indicate that carnitine deficiency and relative insufficiency may be an overlooked component in the management of diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816861     DOI: 10.1001/archpedi.1989.02150230095030

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  12 in total

1.  Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase.

Authors:  Jingli Wang; Anna Alexanian; Rong Ying; Tinoy J Kizhakekuttu; Kodlipet Dharmashankar; Jeanette Vasquez-Vivar; David D Gutterman; Michael E Widlansky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

Review 2.  Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2011-12-02       Impact factor: 5.614

3.  Obesity and lipid stress inhibit carnitine acetyltransferase activity.

Authors:  Sarah E Seiler; Ola J Martin; Robert C Noland; Dorothy H Slentz; Karen L DeBalsi; Olga R Ilkayeva; Jie An; Christopher B Newgard; Timothy R Koves; Deborah M Muoio
Journal:  J Lipid Res       Date:  2014-01-06       Impact factor: 5.922

4.  [Decreased plasma carnitine in Type I diabetes mellitus].

Authors:  P Pregant; G Schernthaner; E Legenstein; L Lienhart; S Bruck; C Schnack; E Kaiser
Journal:  Klin Wochenschr       Date:  1991-08-16

5.  No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.

Authors:  P Pregant; E Kaiser; G Schernthaner
Journal:  Clin Investig       Date:  1993-08

6.  Valproate encephalopathy and hypocarnitinaemia in diabetic patients.

Authors:  L Averbuch-Heller; T Ben-Hur; A Reches
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

7.  Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.

Authors:  Jose Luis Santiago; Alfonso Martínez; Hermenegildo de la Calle; Miguel Fernández-Arquero; M Angeles Figueredo; Emilio G de la Concha; Elena Urcelay
Journal:  BMC Med Genet       Date:  2006-06-23       Impact factor: 2.103

Review 8.  Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine Homeostasis.

Authors:  Judit Bene; Andras Szabo; Katalin Komlósi; Bela Melegh
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

9.  Carnitine supplementation to obese Zucker rats prevents obesity-induced type II to type I muscle fiber transition and favors an oxidative phenotype of skeletal muscle.

Authors:  Aline Couturier; Robert Ringseis; Frank-Christoph Mooren; Karsten Krüger; Erika Most; Klaus Eder
Journal:  Nutr Metab (Lond)       Date:  2013-07-10       Impact factor: 4.169

10.  Alterations of the Lipid Metabolome in Dairy Cows Experiencing Excessive Lipolysis Early Postpartum.

Authors:  Elke Humer; Annabella Khol-Parisini; Barbara U Metzler-Zebeli; Leonhard Gruber; Qendrim Zebeli
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.